ATE212853T1 - Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten - Google Patents

Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten

Info

Publication number
ATE212853T1
ATE212853T1 AT98954551T AT98954551T ATE212853T1 AT E212853 T1 ATE212853 T1 AT E212853T1 AT 98954551 T AT98954551 T AT 98954551T AT 98954551 T AT98954551 T AT 98954551T AT E212853 T1 ATE212853 T1 AT E212853T1
Authority
AT
Austria
Prior art keywords
hydroxyproline
combination
compositions containing
oral compositions
salmon dna
Prior art date
Application number
AT98954551T
Other languages
English (en)
Inventor
Henri Cousse
Jean-Jacques Potherat
Max Rouanet
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of ATE212853T1 publication Critical patent/ATE212853T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT98954551T 1997-11-10 1998-11-10 Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten ATE212853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714093A FR2770777B1 (fr) 1997-11-10 1997-11-10 Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
PCT/FR1998/002398 WO1999024046A1 (fr) 1997-11-10 1998-11-10 Composition orale synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline

Publications (1)

Publication Number Publication Date
ATE212853T1 true ATE212853T1 (de) 2002-02-15

Family

ID=9513209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954551T ATE212853T1 (de) 1997-11-10 1998-11-10 Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten

Country Status (5)

Country Link
EP (1) EP1030677B1 (de)
AT (1) ATE212853T1 (de)
DE (1) DE69803798T2 (de)
FR (1) FR2770777B1 (de)
WO (1) WO1999024046A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333755C (en) * 1998-06-05 2012-11-27 Nutramax Laboratories, Inc. The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
FR2804602B1 (fr) * 2000-02-09 2004-11-19 Serobiologiques Lab Sa Preparations cosmetiques
JP2002080321A (ja) * 2000-06-20 2002-03-19 Kyowa Hakko Kogyo Co Ltd 化粧料
US6497889B2 (en) * 2000-06-20 2002-12-24 Kyowa Hakko Kogyo Co., Ltd. Cosmetics
CA2433714C (en) 2001-01-05 2009-03-03 Kyowa Hakko Kogyo Co., Ltd. Arthritis preventing or treating agent
US20090062371A1 (en) 2006-03-23 2009-03-05 Kyowa Hakko Kogyo Co., Ltd. Oral preparation for promoting synthesis of tissue collagen
WO2008146907A1 (ja) * 2007-06-01 2008-12-04 Kyowa Hakko Bio Co., Ltd. 経口組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
FR2632186B1 (fr) * 1988-06-03 1992-03-13 Fabre Pierre Cosmetique Compositions dermatocosmetologiques pour le traitement de la senescence cutanee et la prevention des rides
JPH0551400A (ja) * 1991-08-21 1993-03-02 Kanegafuchi Chem Ind Co Ltd 短鎖コラーゲン
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale

Also Published As

Publication number Publication date
DE69803798T2 (de) 2002-10-24
FR2770777A1 (fr) 1999-05-14
EP1030677A1 (de) 2000-08-30
FR2770777B1 (fr) 2000-02-25
EP1030677B1 (de) 2002-02-06
DE69803798D1 (de) 2002-03-21
WO1999024046A1 (fr) 1999-05-20

Similar Documents

Publication Publication Date Title
ATE67196T1 (de) Aminosaeureabkoemmlinge.
DE3686525D1 (de) Hochfeste einkristall-superlegierungszusammensetzungen.
MX9203026A (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen.
FI955336A7 (fi) Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, nii den komplekseja ja johdannaisia
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
FR2710063B1 (fr) 3-Aryl-benzofurannones, utilisées en tant que stabilisants, compositions les contenant, et leur utilisation.
BR0211390A (pt) Tratamento de infecções da unha com no
DE3767549D1 (de) Antimikrobielle konservierungszusammensetzungen.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
ATE212853T1 (de) Synergistische orale zusammensetzungen, die eine kombination von lachs-dna mit hydroxyprolin enthalten
ES2173378T3 (es) Material cristalino microporoso, procedimiento para su preparacion y su utilizacion en composiciones detergentes.
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
EA200000884A1 (ru) Производные стрептограминов, их получение и содержащие их композиции
EA200501231A1 (ru) Применение дипиридамола в комбинации с ацетилсалициловой кислотой и антагонистом ангиотензина ii для предупреждения инсульта
FI864795A0 (fi) Komposition innehaollande primicin.
DE3884867D1 (de) Schmiermittel- und Brennstoffzusammensetzungen, die im wesentlichen geradkettige Alkylphenylpolyoxypropylenaminocarbamate enthalten.
RU97111095A (ru) Препарат для профилактики и лечения гельминтозов животных "альбамелин"
RU97113614A (ru) Состав для предотвращения карбонатных отложений
BR0112878A (pt) Composição farmacêutica tendo atividade especìfica em água
RU96107872A (ru) Крем для кожи лица "talita"
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
RU2001128736A (ru) Способ нормализации воспроизводительной функции коров

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification